Clinical Trial of EPASS With Hot AXIOS System

Inclusion Criteria: * Unresectable malignant duodenal obstruction confirmed by biopsy * Eligible for endoscopic intervention * GOOSS score of 0 or 1 * 18 years of age or older * Willing and able to comply with the study procedures or legally authorized representative (LAR) must provide written informed consent form (ICF) to participate in the study Exclusion Criteria: * GOO symptoms are not expected to improve after the index procedure * Life expectancy is about 3 months or less, which is not assumed applicable for surgical GJ * Prior metallic stent placement for GOO * Contraindicated to surgery and general anesthesia * Neoplasm invading the target site of puncture in gastric and/or jejunum * Abnormal coagulation INR \> 1.5 and not correctable (per the discretion of the physician) or who require continuous complete anticoagulation * Bleeding diathesis * Altered anatomy of the upper gastrointestinal tract due to surgery of esophagus, stomach and duodenum that might preclude endoscopic drainage * Presence of ileus caused by peritoneal carcinomatosis, or expected to present within 30 days post procedure * Intervening gastric varices or vessels at the target site of stent insertion * Ascites that may interfere the safety of the index procedure * Biliary tract obstruction requiring treatment at the same day of the index procedure * Allergic to any of the device materials * Contraindications to use of electrosurgical devices * Pregnancy, breastfeeding or intending to become preg…